Literature DB >> 15027048

Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin.

Frank J Erbguth1.   

Abstract

Food-borne botulism probably has accompanied mankind since its beginning. However, we have only few historical sources and documents on food poisoning before the 19th century. Some ancient dietary laws and taboos may reflect some knowledge about the life-threatening consumption of poisoned food. One example of such a dietary taboo is the 10th century edict of Emperor Leo VI of Byzantium in which manufacturing of blood sausages was forbidden. Some ancient case reports on intoxications with Atropa belladonna probably described patients with food-borne botulism, because the combination of dilated pupils and fatal muscle paralysis cannot be attributed to an atropine intoxication. At the end of the 18th century, some well-documented outbreaks of "sausage poisoning" in Southern Germany, especially in Württemberg, prompted early systematic botulinum toxin research. The German poet and district medical officer Justinus Kerner (1786-1862) published the first accurate and complete descriptions of the symptoms of food-borne botulism between 1817 and 1822. Kerner did not succeed in defining the suspected "biological poison" which he called "sausage poison" or "fatty poison." However, he developed the idea of a possible therapeutic use of the toxin. Eighty years after Kerner's work, in 1895, a botulism outbreak after a funeral dinner with smoked ham in the small Belgian village of Ellezelles led to the discovery of the pathogen Clostridium botulinum by Emile Pierre van Ermengem, Professor of bacteriology at the University of Ghent. The bacterium was so called because of its pathological association with the sausages (Latin word for sausage = "botulus") and not-as it was suggested-because of its shape. Modern botulinum toxin treatment was pioneered by Alan B. Scott and Edward J. Schantz. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027048     DOI: 10.1002/mds.20003

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

Review 1.  From poison to remedy: the chequered history of botulinum toxin.

Authors:  F J Erbguth
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

2.  The history of Botulinum toxin: from poison to beauty.

Authors:  Katlein França; Anagha Kumar; Massimo Fioranelli; Torello Lotti; Michael Tirant; Maria Grazia Roccia
Journal:  Wien Med Wochenschr       Date:  2017-03-15

3.  Botulinum Neurotoxins: Mechanism of Action.

Authors:  O Rossetto; M Pirazzini; F Fabris; C Montecucco
Journal:  Handb Exp Pharmacol       Date:  2021

Review 4.  New intraprostatic injectables and prostatic urethral lift for male LUTS.

Authors:  Giuseppe Magistro; Christian G Stief; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2015-07-21       Impact factor: 14.432

Review 5.  Lacrimal gland botulinum toxin injection for epiphora management.

Authors:  Johnathan Jeffers; Katherine Lucarelli; Sruti Akella; Pete Setabutr; Ted H Wojno; Vinay Aakalu
Journal:  Orbit       Date:  2021-08-15

6.  The surgical management of the refractory overactive bladder.

Authors:  Nikhil Vasdev; Benjamin D Biles; Raveen Sandher; Tahseen S Hasan
Journal:  Indian J Urol       Date:  2010-04

7.  Ultrasound-guided injection of botulinum toxin A in the treatment of iliopsoas spasticity.

Authors:  L M Sconfienza; N Perrone; F Lacelli; C Lentino; G Serafini
Journal:  J Ultrasound       Date:  2008-07-03

Review 8.  The role of neuromodulation in patients with neurogenic overactive bladder.

Authors:  Aaron H Lay; Anurag K Das
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

Review 9.  Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury.

Authors:  Ramiro Palazón-García; Ana María Benavente-Valdepeñas
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

Review 10.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.